Andrew Carlsen

Andrew Carlsen is the current Senior Director of Investor Relations at Genmab. Prior to this, they worked as an equity research analyst at ABG Sundal Collier from January 2015 to February 2019. Before that, they were a global portfolio manager at Novo Nordisk A/S from February 2013 to January 2015. Carlsen also worked as an equity analyst at Handelsbanken Capital Markets from December 2010 to February 2013, where they were responsible for small and mid-cap companies. Andrew also worked as an equity analyst at Saxo Bank from June 2009 to November 2010, where they were part of developing the Saxo Bank Equity Research platform. Carlsen began their career as an equity analyst at FIH Erhvervsbank A/S in June 2008 and left in February 2009.

Andrew Carlsen completed a Master of Science in Economics at Københavns Universitet and then went on to complete graduate studies in finance and economics at University of Wisconsin-Madison.

Andrew Carlsen reports to Marisol Peron, Corporate Vice President, Communications & Investor Relations.